These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 900358)

  • 21. Action of dantrolene sodium in spasticity with low dependence on fusimotor drive.
    Knutsson E; Martensson A
    J Neurol Sci; 1976 Oct; 29(2-4):195-212. PubMed ID: 135820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy: spasticity (first of two parts).
    Young RR; Delwaide PJ
    N Engl J Med; 1981 Jan; 304(1):28-33. PubMed ID: 6448959
    [No Abstract]   [Full Text] [Related]  

  • 23. Dantrolene sodium (Dantrium).
    Drug Ther Bull; 1976 Jul; 14(16):61-3. PubMed ID: 964132
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
    van Laere M; Leus P; Mastelinck C
    J Belge Med Phys Rehabil; 1978; 1(2):189-99. PubMed ID: 757420
    [No Abstract]   [Full Text] [Related]  

  • 25. Spasticity and the effect of dantrolene sodium.
    Monster AW
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract]   [Full Text] [Related]  

  • 26. Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study.
    Katrak PH; Cole AM; Poulos CJ; McCauley JC
    Arch Phys Med Rehabil; 1992 Jan; 73(1):4-9. PubMed ID: 1729971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative study for assessing the effects of a pharmacological agent on spasticity.
    Monster AW; Herman R; Meeks S; McHenry J
    Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of spasticity with dantrolene sodium].
    Winnem M
    Tidsskr Nor Laegeforen; 1980 Oct; 100(29):1727-8. PubMed ID: 7008246
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of dantrolene sodium on the incidence of seizures in children with spasticity.
    Nogen AG
    Childs Brain; 1979; 5(4):420-5. PubMed ID: 378580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relief of myotonia by dantrolene in experimental myotonia.
    Eberstein A; Goodgold J
    Exp Neurol; 1978 Dec; 62(3):804-9. PubMed ID: 750223
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of dantrolene sodium on spasticity associated with hemiplegia.
    Steinberg FU; Ferguson KL
    J Am Geriatr Soc; 1975 Feb; 23(2):70-3. PubMed ID: 1141624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dantrium in the treatment of increased muscle tonus in patients with multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1977; 11(1):117-21. PubMed ID: 320494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myo-relaxant action of sodium Dantrolene in the treatment of tetanus].
    Rocha H
    Rev Inst Med Trop Sao Paulo; 1975; 17(4):257-62. PubMed ID: 1181641
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of spasticity in neurological disease by dantrolen-sodium (author's transl)].
    Chantraine A; van Ouwenaller C
    Nervenarzt; 1980 Jan; 51(1):50-4. PubMed ID: 7393365
    [No Abstract]   [Full Text] [Related]  

  • 35. Dantrolene sodium in children with spasticity.
    Haslam RH; Walcher JR; Lietman PS; Kallman CH; Mellits ED
    Arch Phys Med Rehabil; 1974 Aug; 55(8):384-8. PubMed ID: 4604292
    [No Abstract]   [Full Text] [Related]  

  • 36. Dantrolene sodium: long-term effects in severe spasticity.
    Chyatte SB; Basmajian JV
    Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT; Lee RH; Spehlmann R
    Trans Am Neurol Assoc; 1975; 100():235-7. PubMed ID: 1226625
    [No Abstract]   [Full Text] [Related]  

  • 39. [Endocrinologic features and the effect of dantrolene sodium in a subject with recurrent muscle spasms (author's transl)].
    Takeuchi A; Kobayashi I; Nagasawa T; Nakazawa T; Inui S
    Nihon Naika Gakkai Zasshi; 1976 Aug; 65(8):778-84. PubMed ID: 988100
    [No Abstract]   [Full Text] [Related]  

  • 40. Dantrolene sodium: an effective therapeutic agent for the treatment of spasticity in children.
    García-Castro JM
    Bol Asoc Med P R; 1977 Aug; 69(8):263-5. PubMed ID: 334191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.